Literature DB >> 17183918

Acclimation to intermittent hypobaric hypoxia modifies responses to cold at sea level.

Jean-Claude Launay1, Yves Besnard, Angélique Guinet-Lebreton, Gustave Savourey.   

Abstract

INTRODUCTION: Residence at high altitude modifies thremoregulatory responses to cold stress upon return to lower altitude. These changes are difficult to explain since several stresses related to high altitude may interact, including hypoxia, cold, solar radiation, and physical exertion. We hypothesized that adaptation to hypoxia without cold exposure would produce at least part of the observed changes.
METHODS: Five men underwent acclimation to intermittent hypoxia (AIH) in a hypobaric chamber (8 h daily for 4 d, and 6 h on the last day, 4500 to 6000 m) at 24 degrees C. Cold stress responses were tested during a whole-body standard cold air test (1 degrees C, 2 h at rest at sea level) both before and after AIH.
RESULTS: Increased reticulocyte counts and percentages confirmed acclimation to hypoxia after AIH. Changes in thermoregulation during the cold test included lower mean skin temperature after 60-80 min (18.8 +/- 0.7 degrees C vs. 19.4 +/- 0.7 degrees C); higher mean metabolic heat production (127 +/- 8 W x m(-2) vs. 118 +/- 6 W x m(-2)); and lower heat debt (7.7 +/- 1.3 kJ x kg(-1) vs. 10.3 +/- 1.2 kJ x kg(-1)), without significant change in rectal temperature. Time to onset for continuous shivering decreased after AIH (12 +/- 5 min vs. 21 +/- 6.3 min), and shivering activity occurred at higher mean skin but not rectal temperatures.
CONCLUSION: AIH in comfortable ambient temperature leads to a normothermic-insulative-metabolic general cold adaptation. We conclude that AIH modifies the thermoregulatory responses to cold at sea level without cold exposure leading to a cross-adaptation.

Entities:  

Mesh:

Year:  2006        PMID: 17183918

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  7 in total

1.  Testing the nanoparticle-allostatic cross-adaptation-sensitization model for homeopathic remedy effects.

Authors:  Iris R Bell; Mary Koithan; Audrey J Brooks
Journal:  Homeopathy       Date:  2013-01       Impact factor: 1.444

2.  Nonlinear effects of nanoparticles: biological variability from hormetic doses, small particle sizes, and dynamic adaptive interactions.

Authors:  Iris R Bell; John A Ives; Wayne B Jonas
Journal:  Dose Response       Date:  2013-11-07       Impact factor: 2.658

3.  Intermittent hypoxia mobilizes hematopoietic progenitors and augments cellular and humoral elements of innate immunity in adult men.

Authors:  Tatiana V Serebrovskaya; Igor S Nikolsky; Valentyna V Nikolska; Robert T Mallet; Vadim A Ishchuk
Journal:  High Alt Med Biol       Date:  2011       Impact factor: 1.981

4.  Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public Health.

Authors:  Iris R Bell; Gary E Schwartz; Nancy N Boyer; Mary Koithan; Audrey J Brooks
Journal:  Eur J Integr Med       Date:  2013-04-01       Impact factor: 1.314

5.  Modulations of Neuroendocrine Stress Responses During Confinement in Antarctica and the Role of Hypobaric Hypoxia.

Authors:  Claudia Strewe; Detlef Thieme; Carole Dangoisse; Barbara Fiedel; Floris van den Berg; Holger Bauer; Alex P Salam; Petra Gössmann-Lang; Patrizia Campolongo; Dominique Moser; Roel Quintens; Marjan Moreels; Sarah Baatout; Eberhard Kohlberg; Gustav Schelling; Alexander Choukèr; Matthias Feuerecker
Journal:  Front Physiol       Date:  2018-11-26       Impact factor: 4.566

6.  A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system.

Authors:  Iris R Bell; Mary Koithan
Journal:  BMC Complement Altern Med       Date:  2012-10-22       Impact factor: 3.659

7.  Hypoxia induces no change in cutaneous thresholds for warmth and cold sensation.

Authors:  U L Malanda; J P H Reulen; W H M Saris; W D van Marken Lichtenbelt
Journal:  Eur J Appl Physiol       Date:  2008-03-26       Impact factor: 3.078

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.